Keeping Up With Guidelines for Treating Type 2 Diabetes Mellitus to Overcome Clinical Inertia

ACPE Activity Number: 0204-0000-18-424-H01-P
Release Date September 5, 2018
Expiration Date: May 31, 2020
Activity Type: Knowledge-based
CE Credits: 1.0 hours (0.1 CEUs)
Activity Fee: Free of charge

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience

This continuing pharmacy education activity was planned to meet the needs of pharmacists with an interest in diabetes management and new drug therapies who practice in hospitals, ambulatory care clinics, specialty pharmacies, and community pharmacies.

Activity Overview

This 1-hour CE discussion guide will provide an overview of the current diabetes guidelines and the challenge of clinical inertia when caring for patients with diabetes. The use of individualized therapy will be explained.

Learning Objectives

At the conclusion of this knowledge-based activity, participants should be able to

  • Describe the prevalence, clinical and economic impact, and pathogenesis of type 2 diabetes mellitus in the United States.
  • Discuss similarities and differences among the A1C goals in current guidelines for the management of type 2 diabetes mellitus.
  • Review the stepwise approach to drug therapy for type 2 diabetes mellitus.
  • Explain the potential clinical and economic impact of and factors contributing to clinical inertia in treating patients with type 2 diabetes mellitus.
  • List strategies for overcoming clinical inertia in the treatment of type 2 diabetes mellitus.



More information on this educational activity can be found by clicking below.